Ridge Thomas J 4

4 · SKYX Platforms Corp. · Filed Apr 2, 2026

AI-generated summary of this filing

Updated Apr 2, 2026

SKYX Director Ridge Thomas J Receives 10,000-Unit Award

What Happened

Ridge Thomas J, a director of SKYX Platforms Corp. (SKYX), received awards on 2026-03-31: 5,000 shares of restricted stock that vested immediately and a separate grant of 5,000 option units (reported as a derivative award). Both grants show an acquisition price of $0.00 in the Form 4 filing and were issued under the company’s non-employee director compensation program. These were grants/awards (not open-market purchases or sales).

Key Details

Transaction date: 2026-03-31; Filing date: 2026-04-02 (appears timely under the two-business-day Form 4 rule).
Reported price: $0.00 for both the 5,000 restricted shares and the 5,000-option award.
Shares owned after transaction: filing does not disclose total beneficial ownership. The 5,000 restricted shares vested immediately and are owned by the insider; the 5,000 options remain subject to vesting.
Footnotes: F1 — the 5,000 shares are restricted stock that vested immediately under the non-employee director compensation program. F2 — the 5,000 option units vest in twelve equal monthly installments on the last day of each month beginning April 30, 2026.
No indication of a 10b5-1 plan, tax withholding sale, or late filing flag in the provided data.

Context

The restricted stock grant vested immediately, so those shares are now owned by the director. The derivative award represents options (or option-like units) that will vest monthly over one year beginning 4/30/2026; they are not exercised or sold at grant.
These types of awards are common as routine director compensation and are different from open-market buys or insider sales. The filing is informational and does not by itself indicate the director’s market view.

Form 4

Period: 2026-03-31

Director

Transactions

Award
Common Stock, no par value
[F1]
2026-03-31+5,000→ 1,068,193 total
Award
Stock Option (right to buy)
[F2]
2026-03-31+5,000→ 5,000 total
Exercise: $1.12From: 2026-04-30Exp: 2031-03-31→ Common Stock, no par value (5,000 underlying)

Holdings

Stock Option (right to buy)
Exercise: $3.00From: 2017-12-31Exp: 2027-04-19→ Common Stock, no par value (166,667 underlying)
166,667
Stock Option (right to buy)
Exercise: $4.00From: 2018-12-31Exp: 2027-04-19→ Common Stock, no par value (166,667 underlying)
166,667
Stock Option (right to buy)
Exercise: $5.00From: 2019-12-31Exp: 2027-04-19→ Common Stock, no par value (166,666 underlying)
166,666
Stock Option (right to buy)
Exercise: $12.00From: 2021-12-31Exp: 2026-12-31→ Common Stock, no par value (25,000 underlying)
25,000
Stock Option (right to buy)
Exercise: $12.34From: 2022-03-31Exp: 2027-03-11→ Common Stock, no par value (5,000 underlying)
5,000
Stock Option (right to buy)
Exercise: $3.28From: 2023-04-30Exp: 2028-04-05→ Common Stock, no par value (5,000 underlying)
5,000
Stock Option (right to buy)
Exercise: $1.09From: 2024-04-30Exp: 2029-04-04→ Common Stock, no par value (5,000 underlying)
5,000
Stock Option (right to buy)
Exercise: $1.26From: 2025-03-31Exp: 2030-03-27→ Common Stock, no par value (5,000 underlying)
5,000

Footnotes (2)

[F1]Represents shares of restricted stock, which vested immediately upon grant and were granted pursuant to the non-employee director compensation program.
[F2]Options vest in twelve equal monthly installments, on the last day of each month, beginning on April 30, 2026. These options were granted pursuant to the non-employee director compensation program.

Signature

/s/ Marc-Andre Boisseau for Thomas J. Ridge by Power of Attorney|2026-04-02

1 file